Background and Aims: Hepatitis B virus (HBV) infection is a worldwide problem. It is
estimated that 400 million people are suffering from this infection. We conducted a …

Hepatopulmonary syndrome (HPS) is a frequent pulmonary complication of end-stage liver
disease, characterized by impaired arterial oxygenation induced by intrapulmonary vascular …

Hepatopulmonary syndrome (HPS) and porto-pulmonary hypertension (PoPH) represent
relatively common pulmonary vascular complications of advanced liver disease. Despite …

Hepatopulmonary syndrome (HPS) is characterized as a triad: liver disease, intrapulmonary
vascular dilatation and arterial hypoxemia. HPS is reported to be present in 4% to 32% of …

A severe and common pulmonary vascular complication of liver disease is hepatopulmonary
syndrome (HPS). It is a triad of liver dysfunction and/or portal hypertension, intrapulmonary …

The hepatopulmonary syndrome is characterized as the triad of liver disease, pulmonary
gas exchange abnormalities leading to arterial deoxygenation and evidence of …

Hepatopulmonary syndrome (HPS) is a pulmonary complication observed in patients with
chronic liver disease and/or portal hypertension, attributable to an intrapulmonary vascular …

Context Hepatopathies can significantly influence both veins and arteries, these changes
may cause some cutaneous stigmas, such as spider angioma (SA) and some systemic …

AIM: To investigate the prevalence of chronic dyspnea and its relationship to respiratory
muscle function in end-stage liver disease. METHODS: Sixty-eight consecutive, ambulatory …

BACKGROUND All conditions that interfere with blood flow at any level within the portal
system can lead to portal hypertension. For better management of this disorder, it is …